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Summary of Findings 
 
Although pregnancy-associated death remains an infrequent event in Massachusetts, disparities by 
race/ethnicity, age, insurance type, and cause of death remain. The following highlights some key 
findings contained in this report:  
 
 The overall pregnancy-associated mortality ratio (PAMR) was 26.1 per 100,000 live births and did 
not change significantly over the eight-year period. 
 
 The pregnancy-related mortality ratio (PRMR) was 7.9 per 100,000 live births and did not change 
significantly over the eight-year period.  
 
 Black non-Hispanic women had a higher PAMR than women in other racial ethnic groups and 
their risk of dying was 1.9 times higher compared to white non-Hispanic women.  
 
 Younger (<30) and older (≥35) women were more likely to die compared to women aged 30-34 
years. 
 
 Compared to women who had private insurance, those who had public insurance were 2.7 times as 
likely to die during pregnancy or within one year postpartum.  
 
 Women with a high school education or less were more likely to die from any pregnancy-
associated cause.  
 
 The mortality ratios for medical and injury deaths were 17.4/100,000 and 7.9/100,000 live births, 
respectively. 
 
 Complications of pregnancy, labor or delivery were the leading causes of pregnancy-related 
deaths.  
 
 Cardiovascular diseases and cancer were the leading cause of pregnancy-associated but not 
pregnancy-related deaths.   
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I. Purpose 
 
The purpose of this report is to present data on maternal deaths and pregnancy-associated mortality 
from 2000 through 2007 in Massachusetts. This report also suggests strategies for improving maternal 
health outcomes. This report covers both medical and injury-related deaths of women who died while 
pregnant or within one year postpartum. 
 
II. Background 
 
Maternal death, a sentinel event, has dramatically decreased in Massachusetts over the last century. 
There is a long history of reviewing maternal deaths in Massachusetts which began as a systematic 
effort in 1941 when the Committee on Maternal Welfare of the Massachusetts Medical Society 
initiated case reviews of maternal deaths with the goal of improving maternal health.  Since 1997, the 
Massachusetts Department of Public Health (MDPH) has convened the Maternal Mortality and 
Morbidity Review Committee (MMMRC) to review maternal deaths, study the incidence of pregnancy 
complications, and make recommendations to improve maternal outcomes and eliminate preventable 
maternal death.  Understanding the causes of these deaths provides insight into the factors that 
contributed to both maternal morbidity and mortality, which can inform strategies to reduce the 
incidence of these tragic events.  
 
The work of the MMMRC, protected under M.G.L. c. 111, section 24A and 24B, assures the 
confidentiality of all records and proceedings. The committee consists of obstetricians, certified nurse 
midwives, maternal fetal medicine specialists, neonatologists, pathologists, critical care specialist and 
the state medical examiner or his designee (See Appendix A). Since 1997, the MMMRC has reviewed 
and summarized maternal deaths from 1990 to the most current available data. Two previous reports 
were published in 2000 and 2002, respectively; one of which presented the ratios, causes, and timing 
of medical causes of death from 1995 through 1998 and the other summarized the injury deaths from 
1990 to 1999. This report will present findings from reviews of deaths occurring from 2000-2007. 
Over time, definitions of maternal death have evolved and case ascertainment methods have improved, 
but the goal of promoting maternal health has remained unchanged. 
 
Definition of Maternal Death Used in this Study 
 
For the purpose of this report, the MMMRC used the definition of maternal mortality recommended 
by the Maternal Mortality Study Group, a national group jointly chaired by the Division of 
Reproductive Health at the Centers for Diseases Control and Prevention (CDC) and the American 
College of Obstetricians and Gynecologists (ACOG).  The Maternal Mortality Study Group uses the 
term “pregnancy-associated” instead of “maternal” to reflect the inclusion of deaths occurring during 
pregnancy. As such, the definition of a pregnancy-associated death is the death of a woman while 
pregnant or within one year of termination of pregnancy, irrespective of the cause.  
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Pregnancy-associated deaths are divided into three categories: 
  
1. Pregnancy-related. The death of a woman while pregnant or within one year of termination 
of pregnancy, from any cause related to or aggravated by her pregnancy or its management, but 
not from accidental or incidental causes. For example, included under this definition is the 
death of a woman from postpartum hemorrhage or amniotic fluid embolism.  
 
2. Pregnancy-associated-but-not-pregnancy-related. The death of a woman while pregnant or 
within one year of termination of pregnancy due to a cause unrelated to pregnancy. For 
example, the death of a woman from a motor vehicle collision. 
 
3. Pregnancy-associated but undetermined if pregnancy-related. The death of a woman while 
pregnant or within one year of termination of pregnancy from a cause that cannot be 
determined or conclusively categorized as either pregnancy-related or not pregnancy related. 
For example, a woman dies at six months postpartum from a self-inflicted cause with an 
unknown mental health history. 
 
The MMMRC further categorizes these deaths into deaths caused by a medical condition and deaths 
caused by injury. 
 
III. Methods 
 
Case Finding 
 
The MDPH used multiple methods for identifying pregnancy-associated deaths in Massachusetts from 
2000 through 2007. Massachusetts hospitals are mandated by state law to report to the MDPH’s 
Division of Health Care Quality the death of any woman during pregnancy or within 90 days of 
delivery or termination, regardless of the cause of her death, if this death occurs in a hospital setting.  
First, all mandatory reports of maternal death  provided by  hospitals to the MDPH Division of Health 
Care Quality are also provided to the MMMRC. Second, MDPH conducted a manual and automated 
review of death certificates to determine whether there is an indication on the death certificate that a 
woman was pregnant at the time of her death. Third, MDPH employed an enhanced surveillance 
method linking birth certificates and fetal death certificates to death certificates of reproductive-age 
women. This generated a list of all women in Massachusetts who died within one year of being 
pregnant or giving birth. This method captured most pregnancy-associated deaths but may have 
missed a pregnant woman who died before 20 weeks gestation or carried a fetus weighing less than 
350 grams. Fourth, the MDPH also linked maternal death data with the Pregnancy to Early Life 
Longitudinal (PELL) data system. The PELL data system linked the birth certificates and the fetal 
death records to their corresponding hospital discharge data yielding even more information on women 
who died while pregnant or within a year of experiencing a live birth or fetal death. Finally, a small 
number of maternal deaths are identified through newspaper articles, an annual report of women who 
died as a result of domestic violence, or informal reports from MMMRC members or members of the 
obstetric health care community. 
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Case review 
 
For each identified pregnancy-associated death, MDPH staff requested and obtained copies of all 
available hospital medical records related to both the pregnancy and death. A primary and secondary 
reviewer from the MMMRC analyzed all available documents and summarized each case for the entire 
Committee without identifying patients, clinicians, or institutions. In addition, Committee members 
with expertise in oncology, neurology, internal medicine, anesthesiology, pathology, substance use 
disorders, infectious disease, and injury prevention were often asked to review specific cases in their 
field of expertise. After a case was presented by a primary and secondary MMMRC reviewer, the 
entire committee discussed the appropriateness of care and deliberated until consensus on the 
following questions was reached: 
 Was the death pregnancy-related? 
 Was the death preventable? 
 What public health and/or clinical strategies might prevent future deaths? 
 
A ‘preventable medical-related death’ is broadly defined as a death that may have been averted by 
one or more changes in the health care system related to clinical care, facility infrastructure, public 
health infrastructure and/or patient factors. Similarly a ‘preventable injury-related death’ can be 
broadly defined as a death that may have been averted by one or more changes in either the health 
care system or the public services system (transportation as well as social services). 
 
Limitations 
Records that may have provided additional information but were not available to the reviewers 
included ambulatory care records not part of the hospital medical records; hospital records for births or 
fetal deaths occurring outside of Massachusetts; and information about deaths or births occurring in 
non-hospital settings. Other limitations included lack of records from a transferring community 
hospital. 
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IV. Results - Mortality Ratios, Causes, and Timing of Deaths 
 
Pregnancy-Associated Mortality Ratio and Pregnancy-Related Mortality Ratio 
 
From 2000 through 2007, MDPH identified 168 maternal deaths that met the definition of a 
pregnancy-associated death. Of the 168 deaths, 112 (67%) were caused by medical conditions. Of the 
remaining deaths, 51 (30%), were caused by intentional or unintentional injuries and five were due to 
unknown or undetermined causes.  
 
PAMR was defined as the total number of pregnancy-associated deaths over the total number of live 
births. The PAMR over the eight-year period was 26.1 per 100,000 live births. Trend test using 
Joinpoint
1
 showed the PAMR decreased during 2000 to 2003, while it increased from 2003 to 2007. 
The Annual Percent Change (APC) for PAMR was -5.86 in 2000-2003 and 3.07 in 2003-2007, 
respectively, but neither of them was significant (Figure 1).  
 
 
                                                 
1 Joinpoint is a trend analysis tool developed by the National Cancer Institute.  It creates a 
“model” (graph) that best describes the trend in events.  Points where the trend turns around 
are called “joinpoints”.  It shows the Annual Percentage Change (APC) for each line segment in 
the model. 
Figure 1. Pregnancy-Associated Mortality Ratio, Massachusetts, 2000-2007
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PRMR was defined as the total number of pregnancy-related deaths over the total number of live 
births. The overall PRMR over the eight-year period was 7.9 per 100,000 live births. The PRMR 
decreased during 2000 through 2007 with an insignificant APC of -0.33 (Figure 2).  
 
 
 
From 2000 to 2007, the mortality ratios for medical and injury deaths were 17.4/100,000 and 
7.9/100,000 live births, respectively. These ratios cannot be compared to other publications due to 
differences in definitions and case finding methodologies. 
 
 
Figure 2. Pregnancy-Related Mortality Ratio, Massachusetts, 2000-2007
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Pregnancy-Associated Mortality Ratios by Select Maternal Characteristics  
 
 Race/Ethnicity: Overall, black non-Hispanic women were 1.9 times as likely to die during 
pregnancy or within one year postpartum compared to white non-Hispanic women. 
  
 Age: Younger (<30) and older (≥35) women were more likely to die compared to women aged 
30-34 years. 
o Women older than 35 were 2.5 times as likely to die of medical causes than women 
aged 30-34. 
o Women younger than 30 years were 3 times as likely to die of injury than women aged 
30-34. 
 
 Health Insurance at Delivery: Compared to women who had private insurance, those who 
had public insurance were 2.7 times as likely to die during pregnancy or within one year 
postpartum.  
 
 Education of Mother: Women with a high school education or less were more likely to die 
from any pregnancy-associated cause. Compared to women who attained more than 12 years of 
education, the relative risk for those who completed only 12 years of education was 2.3.  Those 
who completed fewer than 12 years of education were 1.7 times as likely to die as women who 
attained more than 12 years of education. 
 
Additional characteristics are presented in Table 1 below. 
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Table 1. Pregnancy-Associated Mortality Ratios by Race, Age, Payer at Delivery, and Education 
Level of Mothers, Massachusetts, 2000-2007 
 
 Frequency Percent (%) PAMR
* Risk Ratio (95% 
Confidence Interval) 
Race/Ethnicity     
Non-Hispanic white 112 64.3 24.5 1.0 
Non-Hispanic black 23 13.1 47.3 1.9 (1.2-3.0) 
Hispanic 19 10.7 23.8 1.0 (0.6-1.6) 
Asian Pacific 9 5.4 21.2 0.9 (0.4-1.7) 
Non-Hispanic American 
Indians and others 
5 3.0 36.1 1.5 (0.6-3.6) 
Age, years     
<30 81 48.2 28.1 1.8 (1.2-2.7) 
30-34 34 20.2 16.4 1.0 
≥35 53 31.6 36.1 2.2 (1.4-3.4) 
Age medical cause only     
<30 45 40.2 15.6 1.4 (0.9-2.2) 
30-34 24 21.4 11.6 1.0 
≥35 43 38.4 29.3 2.5 (1.5-4.1) 
Age, injury cause only     
<30 35 68.6 12.1 3.0 (1.4-6.1) 
30-34 8 15.7 3.9 1.0 
≥35 8 15.7 5.4 1.6 (0.6-3.9) 
Payer at delivery
†     
Private 57 33.9 13.6 1.0 
Public 78 46.4 36.2 2.7 (1.9-3.7) 
Education of mother
‡     
<12 years 19 13.9 26.0 1.7 (1.0-2.8) 
12 years  55 40.2 35.4 2.3 (1.6-3.3) 
>12 years 63 46.0 15.3 1.0 
 
* Per 100,000 live births. 
† Includes 135 deaths of women who had live births and either private or public payers at delivery. Excludes 1 
self-pay, 1 free care, and 33 cases who did not have live births. Private: commercial indemnity plan, 
commercial managed care plan, or other private insurance. Public: Medicaid, Healthy Start (state program for 
low-income women who do not qualify for Medicaid), Medicare, or other government sources. 
‡ Includes 137 deaths of women who had live births. 
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Timing of Pregnancy-Associated Deaths 
 
Although risk for pregnancy-associated death exists throughout pregnancy and the first year 
postpartum, the level of risk varies by period and cause. Among the pregnancy-associated deaths, 
almost half (46%, n=77) occurred either during pregnancy or within 42 days post-partum, and slightly 
more than half (53%, n=89) occurred after 42 days post-partum. 
 
Figure 3. Timing of Pregnancy-Associated Deaths, Massachusetts, 
2000-2007
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Timing of Medical Causes of Death  
 
Of the 112 deaths due to medical causes, 62 occurred either during pregnancy or within 42 days post-
partum.  
 Most (45 out of 62) of the pregnancy-related deaths occurred within 42 days 
postpartum, a time coinciding with close contact with obstetrical providers. 
 
 Among deaths that were not pregnancy-related, most (40 out of 50) occurred after 42 
days postpartum. 
 
 
Figure 4. Timing of Pregnancy-Associated Deaths, Medical Causes, Massachusetts, 
2000-2007
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Timing of Injury Causes of Death 
 
The majority of deaths (38 out of 51) caused by injuries occurred after the 6-week postpartum period 
(43-364 days). 
 The majority of injury deaths were unintentional (35 out of 51). 
 
 The majority of homicide deaths (5 out of 7) and suicide deaths (4 out of 5) occurred in the 43-
364 days postpartum period. 
 
 Deaths due to motor vehicle collisions (MVC) occurred across all periods with over half 
occurring within six months postpartum. 
 
 Most of the deaths due to drug poisoning including overdose (16 out of 19) occurred after the 
6-week postpartum period.  
 
 
Figure 5. Timing of Pregnancy-Associated Deaths, Injury Causes, 
Massachusetts, 2000-2007
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Distribution of Causes of Death 
 
Medical Causes: The distribution of medical causes is presented in Figures 6 and 7. Among the 
112 deaths caused by medical conditions, 51 (45%) were pregnancy-related, 50 (45%) were not related 
to pregnancy, and 11 (10%) were undetermined.  
 
 
The leading causes of pregnancy-related deaths were complications of pregnancy, labor or delivery 
(n=29, 57%), which included  amniotic fluid embolism (n=5), infectious/parasitic disease (n=5), 
cardiovascular disease (n=5), hemorrhage (n=4), pregnancy-induced hypertension (n=3) including 
preeclampsia, eclampsia, and HELLP (Hemolysis, Elevated Liver enzymes, Low Platelet count) 
syndrome, and other complications (n=7) including anesthesia complications, ruptured ectopic 
pregnancy, placental abruption, acute fatty liver, and postpartum angiopathy.  The second leading 
cause was cardiovascular diseases (n=11, 22%). Next, were deaths caused by 
neurology/cerebrovascular diseases (n=4; 8%) and respiratory diseases (n=3, 6%).  
  
Figure 6. Distribution of Pregnancy-Related Deaths Caused by Medical 
Conditions, Massachusetts, 2000-2007
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The leading causes of pregnancy-associated but not pregnancy-related deaths from medical causes 
were cardiovascular diseases (n=15, 30%) followed by cancer (n=13, 26%), infectious and parasitic 
diseases (n=5, 10%) and neurological/cerebrovascular diseases (n=5, 10%). Cancers included breast, 
lung, gastric, esophageal  melanoma, and other rare cancers. Infections included HIV, meningitis, 
pneumonia, hepatitis, myocarditis, panencephalitis, and pyelonephritis. Other causes included seizure 
disorders, metabolic, cerebrovascular diseases, and other rare conditions. 
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Distribution of Injury Deaths: Drug poisoning including drug overdose was the primary cause of 
death among the 51 injury-related deaths and accounted for 37% of the deaths (n=19). The second 
leading cause was motor vehicle collisions (MVC) with 31% (n=16).  Among the remaining deaths, 
14% (n=7) were the result of homicides and 10% (n=5) were suicides. In 8% (n=4) of injury deaths the 
intentionality was undetermined.  
 
Figure 8. Distribution of Injury Deaths, 
Massachusetts, 2000-2007
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Preventable Deaths 
 
The following preventable death determinations were made with the benefit of retrospective review 
and current clinical practice guidelines at the time of the review rather than at the time of the death. 
 
Table 2. Preventable Pregnancy-Associated Deaths, Medical Causes,  
Massachusetts, 2000-2007 
 
 Pregnancy-Related  
Preventability 
Yes No Undetermined Total 
N (%) N (%) N (%) N (%) 
Preventable 12 (24) 9 (18) 0 21 (19) 
Not preventable 22 (43) 35 (70) 3 (27) 60 (54) 
Undetermined 17 (33) 6 (12) 8 (73) 31 (28) 
Total 51 (100) 50 (100) 11 (100) 112 (100) 
  
Overall, 19% (n=21) of the medical deaths may have been “preventable”. The preventability could not 
be determined in 28% of cases (n=31), from the information available at the time of review, and the 
remaining 54% (n=60) were determined by the committee to be not preventable. Among the 
pregnancy-related deaths, 24% (n=12) may have been preventable, and among the deaths not related to 
pregnancy 18% (n=9) may have been preventable.   
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V. Recommendations 
 
The recommendations included in this report are based on the reviews of all pregnancy-associated 
deaths occurring in Massachusetts during 2000-2007 by the MMMRC. These recommendations were 
developed using the framework for public health action developed Dr. Thomas Frieden, current 
Director of the Centers of Disease Control and Prevention (CDC)
2
. Dr. Frieden used a five-tiered 
pyramid to describe different types of public health and clinical interventions. While interventions 
targeted at the base of the pyramid have a greater population impact, a comprehensive public health 
system needs to develop interventions for each tier. In addition, interventions aimed at the top of the 
pyramid require increased individual effort. Using this five-tier pyramid, the recommendations of the 
MMMRC are as follows: 
  
A.   Maternal Counseling and Education:  Maternal counseling is at the individual or group level to 
provide specific information to pregnant and postpartum women. This tier represents health education 
(education provided during clinical encounters as well as education in other settings), which is 
perceived by some as the essence of public health action but is generally the least effective type of 
intervention. The MMMRC had two recommendations: 
 
1. Offer universal screening, including HIV, to all pregnant women. 
 
2. Offer universal screening for smoking and referrals as needed to all pregnant women.
  
3. Offer counseling regarding motor vehicle safety education including seat belt safety.  
 
B.   Perinatal Clinical Interventions: This level of the pyramid represents ongoing clinical 
interventions and direct clinical care. This level, although similar to the fifth  
tier, has the interventions designed to help individuals rather than entire populations, but it could 
theoretically have a large population impact if universally and effectively applied. The MMMRC had 
fourteen recommendations, four of these match the Recommendations to improve maternity care in 
Massachusetts, Report of the Expert Panel in Obstetrics convened by the Betsy Lehman Center for 
Patient Safety and Medical Error Reduction Massachusetts Department of Public Health, November 
18, 2009. * 
 
1. Offer Universal screening, including a rapid HIV test, to all pregnant women.  
 
2. Develop standard practice guidelines for managing pregnant patients for behavioral 
health and mental health.  
 
3. Develop Minimum standards and policies to ensure that all obstetrical providers have 
access to coverage arrangements that allow adequate rest; as needed, adjustments in 
work load and work hours that are consistent with current research should be made.* 
 
                                                 
2
 Frieden, TR. A framework for public health action: the health impact pyramid. Am J Public Health. 2010 Apr;100(4):590-5. Epub 
2010 Feb 18. 
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4. Establish protocols for handing off patients in a structured & consistent manner to 
ensure maximum continuity of information and patient care plans. The prenatal record 
should be available when the patient arrives in L&D.* 
 
 Enhance screening & documentation of screening and response to a positive 
screen during prenatal, intrapartum and postpartum care.  
 The content of the communication should include relevant history such as 
behavioral health issues, pertinent social history, physical and laboratory data 
as well as progress, plans and concerns regarding deterioration.   
 Improve DPH protocols to assure improved data including social work notes. 
 
5. Improve and expand case management to better link social services with medical 
providers including increased case management and/or outreach for women with 
mental health or substance abuse; model could be similar to that of chronic disease. 
 
6. Require that each maternity hospital have clinical guidelines and protocols for 
recognizing and managing maternal hemorrhage including standardized timing and 
criteria for implementing a massive transfusion protocol. The guidelines and protocols 
should include procedures that effectively address the clinical risk and management of 
peripartum maternal hemorrhage. * 
  
7. Establish clear communications of treatment plan to staff, patient, and family which 
include: * 
 Methods for resolving conflicts on patient care management  
 Optimal staffing level, and clear accountability of all relevant staff at all times  
 Prompt disclosure of medical errors and adverse outcomes/events to patient 
and family  
 Linguistic competence, cultural competence and sensitivity in patient care  
 Structured communication (including handoffs and nonverbal communication) 
for all labor and delivery staff  
 Regular assessment of communication skills  
 Work hours and fatigue  
 Hand-offs  
 Availability of prenatal records in Labor & Delivery  
 
8. Develop a checks and balance process to prevent multiple systems error within a 
facility.* 
 
9. Increase training around psychotropic medications.  
 
10. Reduce blood work error by assuring clinical charting & lab work/results are timely 
and noted by clinicians. 
 
11. Establish Quality Assurance (QA) protocols to assure  charts are complete with current 
diagnosis and medications and comprehensive behavioral health care including 
Medication Assisted Therapy (MAT) 
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12.  Improve/expand Case Management (CM) with emphasis on communication regarding: 
history, all social services, risk factors (drugs, depression) to prevent the disconnect 
between a woman’s symptoms and documentation regarding their 
history/contact/involvement with any social services. 
 
13.  Initiate the Screening, Brief Intervention, and Referral and to Treatment (SBIRT) 
protocol (includes, tobacco, alcohol, substance use, mental health and domestic 
violence) as a screening tool to identify high-risk patients. 
 
C.   Universal protocols for preconception, prenatal, intrapartum and postpartum care (including 
baby):  Clinical interventions that require limited contact but confer long-term protection, ongoing 
direct clinical care. The MMMRC committee had eight recommendations: 
 
1. Develop standard practice guidelines for managing patients with diagnosis of Mental 
Health including psychotropic medications and management of maternal health issues.  
 
2. Assure universally accepted drug rehabilitation for all pregnant women that includes 
access and availability. 
  
3. Develop training on maternal mental health and require staff to demonstrate 
proficiency in screening and referring for maternal behavioral health including emotional 
health, unhealthy use of substances and domestic violence.  
 
4. Expand the MMMRC to include a broader array of professional disciplines including, 
but not limited to, medical social workers, providers with specific expertise in substance 
use, mental health and domestic violence.  
 
5. Develop training and require staff to demonstrate proficiency in the administration of 
psychotropic medications in pregnancy. 
  
6. Encourage hospitals to develop community outreach provisions (based on social 
concerns) to all women, especially women who leave against medical advice.  
 
7. Provide comprehensive counseling and/or screening, for Medicated Assisted Therapy 
(MAT) (methadone/suboxone) for pregnant women.  
 
8. Initiate the SBIRT protocol (includes: tobacco, alcohol, substance use, mental health, 
and domestic violence) as a screening tool to identify high risk patients. 
 
D.  Change social and health context to make a woman’s default decisions healthy during her 
childbearing years: Interventions that change the context to make individuals’ default decisions 
healthy. The MMMRC had one recommendation. 
 
1. Ensure all pregnant women receive treatment for substance use disorders. 
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E.  Implement policies to support an environment that promotes healthy women and their families.  At 
the base of this pyramid, which indicates interventions with the greatest potential impact, are efforts to 
address socioeconomic determinants of health. The MMMRC had five recommendations. 
 
1. Create a system of care that includes universal behavioral health services that are 
within societal/governmental responsibility. 
 
2. Ensure universal access to behavioral health services. 
 
3. Explore models of care in other countries. 
 
4. Improve the connection and coordination between social services, health services, and 
the criminal justice system.  
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